{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:12:28Z","timestamp":1790611948020,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012349","name":"School for Public Health Research","doi-asserted-by":"publisher","award":["SPHR-EXE-PES-COM"],"award-info":[{"award-number":["SPHR-EXE-PES-COM"]}],"id":[{"id":"10.13039\/501100012349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peninsula Collaboration for Leadership in Applied Health Research and Care"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["CDF-2012-05-029"],"award-info":[{"award-number":["CDF-2012-05-029"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000385","name":"National Lottery Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Behav Nutr Phys Act"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>This two-site randomised trial compared the effectiveness of a voluntary sector-led, community-based diabetes prevention programme to a waiting-list control group at 6 months, and included an observational follow-up of the intervention arm to 12\u2009months.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Adults aged 18\u201375\u2009years at increased risk of developing type 2 diabetes due to elevated blood glucose and being overweight were recruited from primary care practices at two UK sites, with data collected in participants\u2019 homes or community venues. Participants were randomised using an online central allocation service. The intervention, comprising the prototype \u201cLiving Well, Taking Control\u201d (LWTC) programme, involved four weekly two-hour group sessions held in local community venues to promote changes in diet and physical activity, plus planned follow-up contacts at two, three, six, nine and 12\u2009months alongside 5 hours of additional activities\/classes. Waiting list controls received usual care for 6 months before accessing the programme. The primary outcome was weight loss at 6 months. Secondary outcomes included glycated haemoglobin (HbA1c), blood pressure, physical activity, diet, health status and well-being. Only researchers conducting analyses were blinded.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The target sample of 314 participants (157 each arm) was largely representative of local populations, including 44% men, 26% from ethnic minorities and 33% living in deprived areas. Primary outcome data were available for 285 (91%) participants (141 intervention, 144 control). Between baseline and 6 months, intervention participants on average lost more weight than controls (\u2212\u20091.7\u2009kg, 95% CI \u2212\u20092.59 to \u2212\u20090.85). Higher attendance was associated with greater weight loss (\u2212\u20093.0\u2009kg, 95% CI \u2212\u20094.5 to \u2212\u20091.5). The prototype LWTC programme more than doubled the proportion of participants losing &gt;\u20095% of their body weight (21% intervention vs. 8% control, OR 2.83, 95% CI 1.36 to 5.90) and improved self-reported dietary behaviour and health status. There were no impacts on HbA1c, blood pressure, physical activity and well-being at 6 months and, amongst intervention participants, few further changes from six to 12-months (e.g. average weight re-gain 0.36\u2009kg, 95% CI \u2212\u20090.20 to 0.91). There were no serious adverse events but four exercise-related injuries were reported in the intervention arm.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This voluntary sector-led diabetes prevention programme reached a broad spectrum of the population and had modest effects on weight-related outcomes, but limited impacts on other diabetes risk factors.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>Trial registration number: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1186\/ISRCTN70221670\">ISRCTN70221670<\/jats:ext-link>, 5 September 2014<\/jats:p>\n<jats:p>Funder (National Institute for Health Research School for Public Health Research) project reference number: SPHR-EXE-PES-COM.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12966-019-0877-3","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T02:02:32Z","timestamp":1574820152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The community-based prevention of diabetes (ComPoD) study: a randomised, waiting list controlled trial of a voluntary sector-led diabetes prevention programme"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5658-9334","authenticated-orcid":false,"given":"Jane R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Greaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosy","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Moorlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Solomon-Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele S. Y.","family":"Biddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"877_CR1","unstructured":"International Diabetes Federation. IDF diabetes atlas, 7th edition; 2015 www.diabetesatlas.org (Accessed 30 Jan 2017)."},{"key":"877_CR2","unstructured":"National Institute for Health and Clinical Excellence. Diabetes in adults (QS6). London: NICE; 2011. http:\/\/guidance.nice.org.uk\/QS6 (Accessed 12 Sept 2017)."},{"key":"877_CR3","unstructured":"National Institute for Health and Clinical Excellence. Preventing type 2 diabetes: Risk identification and interventions for individuals at high risk (PH38). London: NICE; 2012. http:\/\/www.nice.org.uk\/PH38 (Accessed 12 Sept 2017)."},{"issue":"6","key":"877_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM. 2002;346(6):393\u2013403.","journal-title":"NEJM"},{"issue":"12","key":"877_CR5","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","volume":"26","author":"J Lindstr\u00f6m","year":"2003","unstructured":"Lindstr\u00f6m J, Louheranta A, Mannelin M, et al. The Finnish diabetes prevention study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230\u20136.","journal-title":"Diabetes Care"},{"issue":"4","key":"877_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/diacare.20.4.537","volume":"20","author":"XR Pan","year":"1997","unstructured":"Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care. 1997;20(4):537\u201344.","journal-title":"Diabetes Care"},{"key":"877_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","volume":"334","author":"CL Gillies","year":"2007","unstructured":"Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007;334:299\u2013308.","journal-title":"BMJ"},{"key":"877_CR8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1136\/bmj.39545.585289.25","volume":"336","author":"CL Gillies","year":"2008","unstructured":"Gillies CL, Lambert PC, Abrams KR, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ. 2008;336:1180\u20135.","journal-title":"BMJ"},{"key":"877_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1055\/s-0029-1240928","volume":"42","author":"B Paulweber","year":"2010","unstructured":"Paulweber B, Valensi P, Lindstr\u00f6m J, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res. 2010;42:S3\u2013S36. https:\/\/doi.org\/10.1055\/s-0029-1240928.","journal-title":"Horm Metab Res"},{"key":"877_CR10","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 5. Prevention or delay of type 2 diabetes. Diabetes Care 2015;38 (Supp 1):S31-S32. doi.org\/10.2337\/dc15-S008.","DOI":"10.2337\/dc15-S008"},{"key":"877_CR11","unstructured":"National Cardiovascular Intelligence Network. NHS diabetes prevention Programme non-diabetic hyperglycaemia. London: Public Health England, 2015. http:\/\/www.yhpho.org.uk\/resource\/view.aspx?RID=213523 (Accessed 30 Jan 2017)."},{"issue":"9833","key":"877_CR12","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for developing diabetes. Lancet. 2012;379(9833):2279\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(12)60283-9.","journal-title":"Lancet"},{"key":"877_CR13","unstructured":"NHS England. NHS Diabetes Prevention Programme (NHS DPP). www.england.nhs.uk\/ourwork\/qual-clin-lead\/diabetes-prevention\/ (Accessed 30 Jan 2017)."},{"key":"877_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/dme.13892","volume":"36","author":"R Taylor","year":"2019","unstructured":"Taylor R, Valabhji J, Aveyard P, Paul D. Prevention and reversal of type 2 diabetes: highlights from a symposium at the 2019 Diabetes UK annual professional conference. Diabet Med. 2019;36:359\u201365. https:\/\/doi.org\/10.1111\/dme.13892.","journal-title":"Diabet Med"},{"issue":"4","key":"877_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.2337\/dc13-2195","volume":"37","author":"A Dunkley","year":"2014","unstructured":"Dunkley A, Bodicoat D, Greaves CJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37(4):922\u201333 doi.org\/10.2337\/dc13-2195.","journal-title":"Diabetes Care"},{"key":"877_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/1471-2458-9-342","volume":"9","author":"L Penn","year":"2009","unstructured":"Penn L, White M, Oldroyd J, Walker M, Alberti KGMM, Mathers JC. Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European diabetes prevention RCT in Newcastle upon Tyne, UK. BMC Public Health. 2009;9:342. https:\/\/doi.org\/10.1186\/1471-2458-9-342.","journal-title":"BMC Public Health"},{"issue":"3","key":"877_CR17","first-page":"218","volume":"2","author":"RS Bhopal","year":"2014","unstructured":"Bhopal RS, Douglas A, Wallia S, et al. Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. Lancet. 2014;2(3):218\u201327.","journal-title":"Lancet"},{"key":"877_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ypmed.2015.12.012","volume":"84","author":"MJ Davies","year":"2016","unstructured":"Davies MJ, Gray LJ, Troughton J, et al. A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let\u2019s prevent diabetes cluster randomised controlled trial. Prev Med. 2016;84:48\u201356. https:\/\/doi.org\/10.1016\/j.ypmed.2015.12.012.","journal-title":"Prev Med"},{"issue":"18","key":"877_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstr\u00f6m J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343\u201350.","journal-title":"N Engl J Med"},{"key":"877_CR20","unstructured":"NHS England. NHS Diabetes Prevention Programme National Service Specification. https:\/\/www.england.nhs.uk\/publication\/nhs-dpp-national-service-specification\/ (Accessed 12 Sept 2017)."},{"key":"877_CR21","unstructured":"Health and Social Care Act 2012, c.7. Available at: http:\/\/www.legislation.gov.uk\/ukpga\/2012\/7\/contents\/enacted (Accessed 24 Feb 2017)."},{"key":"877_CR22","unstructured":"King\u2019s Fund & NCVO, 2011. The Voluntary and Community Sector in Health. Available at: https:\/\/www.kingsfund.org.uk\/sites\/files\/kf\/Voluntary-and-community-sector-in-health-implications-NHS-reforms-The-Kings-Fund-june-2011_0.pdf (Accessed 24 Feb 2017)."},{"issue":"8","key":"877_CR23","doi-asserted-by":"publisher","first-page":"e1000320","DOI":"10.1371\/journal.pmed.1000320","volume":"7","author":"S Capewell","year":"2010","unstructured":"Capewell S, Graham H. Will cardiovascular disease prevention widen health inequalities? PLoS Med. 2010;7(8):e1000320.","journal-title":"PLoS Med"},{"issue":"7","key":"877_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539\u201353.","journal-title":"Diabet Med"},{"key":"877_CR25","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/j.1464-5491.2012.03762.x","volume":"29","author":"WG John","year":"2012","unstructured":"John WG. On behalf of the UK Department of Health Advisory Committee on diabetes. Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011. Diabet Med. 2012;29:1350\u20137.","journal-title":"Diabet Med"},{"key":"877_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1464-5491.2007.02130.x","volume":"24","author":"PH Evans","year":"2007","unstructured":"Evans PH, Greaves C, Winder R, Fearn-Smith J, Campbell JL. Development of an educational \u2018toolkit\u2019 for health professionals and their patients with pre-diabetes: the WAKEUP study (ways of addressing knowledge education and understanding in pre-diabetes). Diabet Med. 2007;24:770\u20137.","journal-title":"Diabet Med"},{"key":"877_CR27","volume-title":"South west well-being Programme final evaluation report","author":"M Jones","year":"2011","unstructured":"Jones M, Kimberlee R, Evans S, Deave T. South west well-being Programme final evaluation report. Bristol: University of the West of England; 2011. https:\/\/www.westbank.org.uk\/Handlers\/Download.ashx?IDMF=0065f36c-81e7-4ce9-b4ba-f6c489f63468 (Accessed 18 Sept 17)."},{"issue":"1","key":"877_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1108\/HE-04-2017-0019","volume":"118","author":"Michele S.Y. Kok","year":"2018","unstructured":"Kok MSY, Jones M, Solomon-Moore E, Smith JR. Implementation fidelity of a voluntary sector-led diabetes education programme. Health Educ 2018;118(1): 62\u201381. doi.org\/10.1108\/HE-04-2017-0019.","journal-title":"Health Education"},{"key":"877_CR29","unstructured":"Kok M, Solomon-Moore E, Greaves C, Smith JR, Kimberlee R, Jones M. Evaluation of living well, Taking Control: A community-based diabetes prevention and management programme. Project Report. UWE Bristol, Bristol, UK; 2016. http:\/\/eprints.uwe.ac.uk\/30234 (Accessed 26 Sept 2017)."},{"key":"877_CR30","unstructured":"McLean G, Tobias M. The New Zealand physical activity questionnaires. Report on the validation and use of the NZPAQ-LF and NZPAQ-SF self-report physical activity survey instruments. Wellington, New Zealand: SPARC; 2004. http:\/\/www.sparc.org.nz\/research-policy\/research\/nzspas-97-01\/nzpaq (Accessed 15 Apr 2014)."},{"key":"877_CR31","first-page":"355","volume":"6","author":"J Shannon","year":"1997","unstructured":"Shannon J, Kristal SJ, Beresford SAA. Application of a behavioural approach to measuring dietary change: the fat- and fiber-related diet behaviour questionnaire. Cancer Epidemiol Biomark Prev. 1997;6:355\u201361.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"877_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12889-016-3929-5","volume":"17","author":"M Pascale","year":"2017","unstructured":"Pascale M, Murray N, Bachmann M, et al. Study protocol: the Norfolk diabetes prevention study [NDPS]: a 46 month multi-Centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with type 2 diabetes] to prevent transition to type 2 diabetes in high risk groups with non-diabetic hyperglycaemia, or impaired fasting glucose. BMC Public Health. 2017;17:31.","journal-title":"BMC Public Health"},{"issue":"5","key":"877_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1477-7525-5-63","volume":"27","author":"R Tennant","year":"2007","unstructured":"Tennant R, Hiller L, Fishwick R, et al. The Warwick-Edinburgh mental well-being scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;27(5):63.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"877_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy"},{"key":"877_CR35","unstructured":"Abdallah S, Steuer N, Marks N, Page N. Well-being evaluation tools: a research and development project for the big Lottery Fund, final report. New economics foundation; 2008. www.biglotteryfund.org.uk\/wellbeing_evaluation_tools.pdf (Accessed 21 Oct 2017)."},{"key":"877_CR36","doi-asserted-by":"publisher","first-page":"d6500","DOI":"10.1136\/bmj.d6500","volume":"343","author":"K Jolly","year":"2011","unstructured":"Jolly K, Lewis A, Beach J, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten up randomised controlled trial. BMJ. 2011;343:d6500.","journal-title":"BMJ"},{"issue":"378","key":"877_CR37","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(11)61344-5","volume":"22","author":"SA Jebb","year":"2011","unstructured":"Jebb SA, Ahern AL, Olson AD, et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet. 2011;22(378):1485\u201392.","journal-title":"Lancet"},{"key":"877_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12966-014-0159-z","volume":"12","author":"CJ Greaves","year":"2015","unstructured":"Greaves CJ, Gillison F, Stathi A, et al. Waste the waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk. Int J Nutrit Beh Phys Activity. 2015;12:1.","journal-title":"Int J Nutrit Beh Phys Activity"},{"issue":"Rr-10","key":"877_CR39","first-page":"1","volume":"54","author":"DL Katz","year":"2005","unstructured":"Katz DL, O'Connell M, Yeh MC, et al. Public health strategies for preventing and controlling overweight and obesity in school and worksite settings: a report on recommendations of the Task Force on Community Preventive Services. MMWR Recommendations and Reports. 2005;54(Rr-10):1\u201312.","journal-title":"MMWR Recommendations and Reports"},{"issue":"553","key":"877_CR40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3399\/bjgp08X319648","volume":"58","author":"CJ Greaves","year":"2008","unstructured":"Greaves CJ, Middlebrooke A, O'Loughlin L, et al. Motivational interviewing for reducing diabetes risk: a randomised controlled trial. Br J Gen Pract. 2008;58(553):535\u201340.","journal-title":"Br J Gen Pract"},{"issue":"119","key":"877_CR41","first-page":"1","volume":"11","author":"CJ Greaves","year":"2011","unstructured":"Greaves CJ, Sheppard KE, Abraham C, et al. Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health. 2011;11(119):1\u201312.","journal-title":"BMC Public Health"},{"issue":"1","key":"877_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2307\/2529712","volume":"31","author":"SJ Pocock","year":"1975","unstructured":"Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1):103\u201315.","journal-title":"Biometrics"},{"key":"877_CR43","unstructured":"van Hees VT, Fang Z, Zhao JH, et al. GGIR: Raw accelerometer data analysis. https:\/\/cran.r-project.org\/web\/packages\/GGIR\/index.html (Accessed 21 Oct 2017)."},{"issue":"10","key":"877_CR44","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1249\/MSS.0000000000000978","volume":"48","author":"AV Rowlands","year":"2016","unstructured":"Rowlands AV, Yates T, Davies M, Khunti K, Edwardson CL. Raw accelerometer data analysis with GGIR R-package: does accelerometer brand matter? Med Sci Sports Exerc. 2016;48(10):1935\u201341.","journal-title":"Med Sci Sports Exerc"},{"key":"877_CR45","volume-title":"Start active, stay active: a report on physical activity from the four home countries\u2019 chief medical officers","author":"Department of Health","year":"2011","unstructured":"Department of Health. Start active, stay active: a report on physical activity from the four home countries\u2019 chief medical officers. London: Department of Health; 2011."},{"issue":"9","key":"877_CR46","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1249\/MSS.0000000000000289","volume":"46","author":"M Hildebrand","year":"2014","unstructured":"Hildebrand M, Van Hees VT, Hansen BH, Ekelund U. Age group comparability of raw accelerometer output from wrist- and hip-worn monitors. Med Sci Sports Exerc. 2014;46(9):1816\u201324.","journal-title":"Med Sci Sports Exerc"},{"key":"877_CR47","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1123\/jpah.8.8.1152","volume":"8","author":"E Gemmill","year":"2011","unstructured":"Gemmill E, Bayles CM, McTigue K, Satariano W, Sharma R, Wilson JW. Factors associated with adherence to an accelerometer protocol in older adults. J Phys Act Health. 2011;8:1152\u20139.","journal-title":"J Phys Act Health"},{"issue":"342","key":"877_CR48","doi-asserted-by":"publisher","first-page":"d40","DOI":"10.1136\/bmj.d40","volume":"7","author":"IR White","year":"2011","unstructured":"White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ. 2011;7(342):d40.","journal-title":"BMJ"},{"issue":"2","key":"877_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/biomet\/86.2.365","volume":"86","author":"CE Frangakis","year":"1999","unstructured":"Frangakis CE, Rubin DB. Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes. Biometrika. 1999;86(2):365\u201379.","journal-title":"Biometrika"},{"key":"877_CR50","doi-asserted-by":"publisher","first-page":"f3748","DOI":"10.1136\/bmj.f3748","volume":"346","author":"P Sedgwick","year":"2013","unstructured":"Sedgwick P. What is per protocol analysis? BMJ. 2013;346:f3748.","journal-title":"BMJ"},{"issue":"3","key":"877_CR51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/0962280209105014","volume":"19","author":"R Emsley","year":"2010","unstructured":"Emsley R, Dunn G, White IR. Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Stat Methods Med Res. 2010;19(3):237\u201370.","journal-title":"Stat Methods Med Res"},{"key":"877_CR52","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1002\/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4","volume":"16","author":"B Brown","year":"1997","unstructured":"Brown B, Russell K. Methods correcting for multiple testing: operating characteristics. Stat Med. 1997;16:2511\u201328.","journal-title":"Stat Med"},{"key":"877_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"L Radloff","year":"1977","unstructured":"Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385\u2013401.","journal-title":"Appl Psychol Meas"},{"issue":"2","key":"877_CR54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s13679-016-0211-1","volume":"5","author":"KH Lewis","year":"2016","unstructured":"Lewis KH, Edwards-Hampton SA, Ard JD. Disparities in treatment uptake and outcomes of patients with obesity in the USA. Curr Obes Rep. 2016;5(2):282\u201390. https:\/\/doi.org\/10.1007\/s13679-016-0211-1.","journal-title":"Curr Obes Rep"},{"key":"877_CR55","unstructured":"Birmingham City Council. 2011 census in Birmingham: Population and migration topic report. https:\/\/www.birmingham.gov.uk\/downloads\/file\/4564\/2011_census_birmingham_population_and_migration_reportpdf (Accessed 27 Jan 2018)."},{"key":"877_CR56","unstructured":"Devon County Council. 2011 census profile: Exeter City. http:\/\/www.devon.gov.uk\/census_profile-exeter.pdf (Accessed 27 Jan 2018)."},{"key":"877_CR57","unstructured":"UK Government Ministry of Housing, Communities & Local Government. English indices of deprivation 2015. https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015 (Accessed 27 Jan 2018)."},{"key":"877_CR58","doi-asserted-by":"crossref","unstructured":"Janssen B, Szende A. Population norms for the EQ-5D. In: Szende A, Janssen B, Cabas\u00e9s J (Eds). Self-reported population health: an international perspective based on EQ-5D. Dordrecht, Netherlands: Springer Open; 2014. p. 31\u201336.","DOI":"10.1007\/978-94-007-7596-1_4"},{"issue":"suppl 1","key":"877_CR59","doi-asserted-by":"publisher","first-page":"i139","DOI":"10.1093\/fampra\/cmr074","volume":"29","author":"The Counterweight Project Team","year":"2012","unstructured":"The Counterweight Project Team. The implementation of the counterweight Programme in Scotland, UK. Fam Pract. 2012;29(suppl 1):i139\u2013i44.","journal-title":"Fam Pract"},{"key":"877_CR60","unstructured":"Clifford Z, Solomon-Moore E, Kimberlee R, Biggs O, Weld S, Blackburn K, Jones M. Social return on investment report (SROI) final report on a type 2 diabetes prevention and management programme delivered by Westbank CHC. UWE Bristol, Bristol, UK; 2015. https:\/\/uwe-repository.worktribe.com\/output\/841398 (Accessed 19 Oct 2019)."},{"key":"877_CR61","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.2337\/dc11-9998","volume":"34","author":"DB Sacks","year":"2011","unstructured":"Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2011;34:e61\u201399.","journal-title":"Diabetes Care"},{"key":"877_CR62","doi-asserted-by":"publisher","first-page":"i6538","DOI":"10.1136\/bmj.i6538","volume":"356","author":"E Barry","year":"2017","unstructured":"Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of t ype 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. 2017;356:i6538.","journal-title":"BMJ"}],"container-title":["International Journal of Behavioral Nutrition and Physical Activity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12966-019-0877-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12966-019-0877-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12966-019-0877-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:07:20Z","timestamp":1606349240000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijbnpa.biomedcentral.com\/articles\/10.1186\/s12966-019-0877-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1186\/s12966-019-0877-3","relation":{},"ISSN":["1479-5868"],"issn-type":[{"value":"1479-5868","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Multi-site ethics approval was obtained prior to commencement of the trial and for subsequent protocol amendments via the North West Lancaster NHS Research Ethics Committee (reference 14\/NW\/1113) who are independent of all the institutions involved and had no role in the design, conduct or reporting of the research. Local NHS research governance approvals were also obtained at the two sites (UK Clinical Research Network (UKCRN) portfolio ID: 17309). All participants provided written informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the Unified Competing Interest form (available on request from the corresponding author) and declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}